18th Annual International Congress on Hematologic Malignancies®
Crowne Plaza
New York, NY
February 14 - 15, 2014
 
31st Annual Miami Breast Cancer Conference®
Fontainebleau Miami Beach
Miami Beach, FL
March 6 - 9, 2014
 
7th Annual Interdisciplinary Prostate Cancer Congress™ (IPCC®)
Corwne Plaza 
New York, NY
March 15, 2014
 
13th Annual International Congress on the Future of Breast Cancer®
Hyatt Regency
Huntington Beach, CA
July 17 - 19, 2014
 
15th Annual International Lung Cancer Congress®
Hyatt Regency
Huntington Beach, CA
July 31 - August 2, 2014

12th Annual International Congress on Targeted Therapies in Cancer®
New York, NY
October 2014

12th Annual School of Breast Oncology®
Emory University Conference Center
Atlanta, GA

November 6 - 9, 2014

9th Annual New York Lung Cancer Symposium®
New York
November 8, 2014




Upcoming AJMC events
With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
Farzad Mostashari, MD, Explains the Blue Button Initiative
Farzad Mostashari, MD, CEO, Aledade Inc, former National Coordinator for Health Information Technology, says that the Blue Button Initiative is a concept that allows patients to receive a copy of their own health information and use it however they like.
 
Eleanor Perfetto, PhD, MS, Discusses How HEOR Departments Use Comparative Effectiveness Research
Comparative effectiveness research (CER) collaborative tools can benefit pharmaceutical companies in a variety of ways.
 
Ira Klein, MD, MBA, FACP, Discusses Payer and ACO Oncology Care Pathways Participation
It is well known that oncology care pathways are the tools that practices can utilize to care for its patients. Ira Klein, MD, MBA, FACP, chief medical officer, National Accounts Clinical Sales & Strategy, Aetna, suggests that Aetna’s only involvement in creating these pathways should be in helping these practices develop “reasonable care pathways.”
Episode 16 - Closing Remarks
As the panel discussion concludes, Peter Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Yehuda Handelsman, MD, FACP, FACE, FNLA; Maria Lopes, MD, MS; and Kari Uusinarkaus, MD, FAAFP, FNLA, share their final insights about managed care models and clinical and economic outcomes in diabetes and obesity.